distributed biomanufacturing

Biopharmaceutical manufacturing is entering a structural transition as decentralized biomanufacturing models gain traction across the United States. Traditional centralized production systems built around large-scale facilities are increasingly challenged by supply chain fragility, capacity bottlenecks, and the growing demand for precision therapeutics. Emerging distributed manufacturing frameworks are now being observed as a strategic pathway to improve … Read more